Form 4: Tyra Biosciences Director Gilla Kaplan Executes Stock Option and Disposes of Shares
SEC Form 4 Filing
Director Gilla Kaplan exercised stock options and disposed of shares of Tyra Biosciences on June 13, 2024.
Summary
- On June 13, 2024, Gilla Kaplan, a director of Tyra Biosciences, Inc. (TYRA), executed a transaction involving the company's common stock.
- Kaplan exercised stock options to acquire 61,392 shares at a price of $0.61 per share.
- Following the transaction, Kaplan disposed of 61,392 shares.
- After the reported transaction, Kaplan beneficially owns 89,623 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 06/13/2024 | Date of transaction: Stock option exercise and share disposal. |
| 01/26/2030 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.